Guy Levy, 10% Owner at Parabilis Medicines, Inc. (PBLS), bought 500,000 shares at $20.00 ($10.0M) on 2026-06-11, disclosed to the SEC on 2026-06-29.
Guy Levy, a 10% holder, purchased $7.5M worth of shares at $20.00, marking the largest insider purchase in the company's history. This significant bet by a major shareholder suggests confidence in the company's pipeline or valuation, particularly as the stock trades near its 52-week low.
The stock is up 6.44% over the last 5 days but remains down 14.48% from its 52-week high of $34.19, trading 18.5% above its 52-week low of $24.675.
The trade itself is a catalyst, as it represents the largest insider purchase in the company's history. Furthermore, the June 11 Barchart article suggests the stock could extend gains following its IPO.
The company reported a net loss of $209.706 million with no reported revenue in the latest analysis. Additionally, the short interest is low at 0.92% of the float, limiting potential short-covering support.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 125,000 | $2.5M | 25.0% |
| 2 | $20.00 | 375,000 | $7.5M | 75.0% |
| Total | $20.00 avg | 500,000 | $10.0M | 100% |
| Filing → |
| BCAB | BUY | 2020-12-22 | $25.0M | — | Filing → |